Cargando…
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
BACKGROUND: The complexity of delivering precision medicine to oncology patients has led to the creation of molecular tumourboards (MTBs) for patient selection and assessment of treatment options. New technologies like the liquid biopsy are augmenting available therapeutic opportunities. This report...
Autores principales: | Rolfo, Christian, Manca, Paolo, Salgado, Roberto, Van Dam, Peter, Dendooven, Amelie, Machado Coelho, Andreia, Ferri Gandia, Jose, Rutten, Annemie, Lybaert, Willem, Vermeij, Joanna, Gevaert, Thomas, Weyn, Christine, Lefebure, Anneke, Metsu, Sofie, Van Laere, Steven, Peeters, Marc, Pauwels, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069914/ https://www.ncbi.nlm.nih.gov/pubmed/30094075 http://dx.doi.org/10.1136/esmoopen-2018-000398 |
Ejemplares similares
-
Clinical performance evaluation of a sensitive, rapid low-throughput test for KRAS mutation analysis using formalin-fixed, paraffin-embedded tissue samples
por: Weyn, Christine, et al.
Publicado: (2017) -
Potential new biomarkers for squamous carcinoma of the uterine cervix
por: van Dam, Peter A, et al.
Publicado: (2018) -
Clinical Trial Accrual: Obstacles and Opportunities
por: Rimel, B. J.
Publicado: (2016) -
Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual
por: Hallquist Viale, Pamela
Publicado: (2016) -
Accrual and retention of diverse patients in psychosocial cancer clinical trials
por: Hanvey, Grace Ann, et al.
Publicado: (2022)